These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 28071754)
1. Far-infrared protects vascular endothelial cells from advanced glycation end products-induced injury via PLZF-mediated autophagy in diabetic mice. Chen CH; Chen TH; Wu MY; Chou TC; Chen JR; Wei MJ; Lee SL; Hong LY; Zheng CM; Chiu IJ; Lin YF; Hsu CM; Hsu YH Sci Rep; 2017 Jan; 7():40442. PubMed ID: 28071754 [TBL] [Abstract][Full Text] [Related]
2. Far-infrared therapy induces the nuclear translocation of PLZF which inhibits VEGF-induced proliferation in human umbilical vein endothelial cells. Hsu YH; Chen YC; Chen TH; Sue YM; Cheng TH; Chen JR; Chen CH PLoS One; 2012; 7(1):e30674. PubMed ID: 22292015 [TBL] [Abstract][Full Text] [Related]
3. Far-infrared radiation prevents decline in β-cell mass and function in diabetic mice via the mitochondria-mediated Sirtuin1 pathway. Hsu YH; Chen YC; Chen YW; Chiu TH; Kuo YT; Chen CH Metabolism; 2020 Mar; 104():154143. PubMed ID: 31927009 [TBL] [Abstract][Full Text] [Related]
4. Far-infrared radiation alleviates cisplatin-induced vascular damage and impaired circulation via activation of HIF-1α. Chen CH; Chen MC; Hsu YH; Chou TC Cancer Sci; 2022 Jun; 113(6):2194-2206. PubMed ID: 35411640 [TBL] [Abstract][Full Text] [Related]
5. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB. Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219 [TBL] [Abstract][Full Text] [Related]
7. Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Han J; Pan XY; Xu Y; Xiao Y; An Y; Tie L; Pan Y; Li XJ Autophagy; 2012 May; 8(5):812-25. PubMed ID: 22622204 [TBL] [Abstract][Full Text] [Related]
8. Paeoniflorin protects HUVECs from AGE-BSA-induced injury via an autophagic pathway by acting on the RAGE. Chen Y; Du X; Zhou Y; Zhang Y; Yang Y; Liu Z; Liu C; Xie Y Int J Clin Exp Pathol; 2015; 8(1):53-62. PubMed ID: 25755692 [TBL] [Abstract][Full Text] [Related]
9. Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis. Yang G; Huang Y; Wu X; Lin X; Xu J; Chen X; Bai X; Li Q Biomed Res Int; 2018; 2018():8216578. PubMed ID: 29850572 [TBL] [Abstract][Full Text] [Related]
10. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway. Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033 [TBL] [Abstract][Full Text] [Related]
11. Methylglyoxal-derived hemoglobin advanced glycation end products induce apoptosis and oxidative stress in human umbilical vein endothelial cells. Lee JH; Samsuzzaman M; Park MG; Park SJ; Kim SY Int J Biol Macromol; 2021 Sep; 187():409-421. PubMed ID: 34271050 [TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis. Zhan Y; Sun HL; Chen H; Zhang H; Sun J; Zhang Z; Cai DH Med Sci Monit; 2012 Jul; 18(7):BR286-91. PubMed ID: 22739729 [TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End Products Inhibit the Proliferation of Human Umbilical Vein Endothelial Cells by Inhibiting Cathepsin D. Li Y; Chang Y; Ye N; Dai D; Chen Y; Zhang N; Sun G; Sun Y Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218663 [TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products of bovine serum albumin affect the cell growth of human umbilical vein endothelial cells via modulation of MEG3/miR-93/p21 pathway. Ju C; Sheng Z; Wang Q; Li Y; Wang X; Li S; Qi Q; Yuan Z Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):41-50. PubMed ID: 30544204 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR‑17‑5p protects against high glucose‑induced endothelial cell injury by targeting E2F1‑mediated suppression of autophagy and promotion of apoptosis. Yuan Y; Li X; Li M Int J Mol Med; 2018 Sep; 42(3):1559-1568. PubMed ID: 29786752 [TBL] [Abstract][Full Text] [Related]
16. Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel-Like Factor 2. Saum K; Campos B; Celdran-Bonafonte D; Nayak L; Sangwung P; Thakar C; Roy-Chaudhury P; Owens AP J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301761 [TBL] [Abstract][Full Text] [Related]
17. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system. Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034 [TBL] [Abstract][Full Text] [Related]
18. Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products. Ishibashi Y; Matsui T; Nakamura N; Sotokawauchi A; Higashimoto Y; Yamagishi SI Diab Vasc Dis Res; 2017 Sep; 14(5):450-453. PubMed ID: 28631505 [TBL] [Abstract][Full Text] [Related]
19. Protective role of autophagy in AGE-induced early injury of human vascular endothelial cells. Xie Y; You SJ; Zhang YL; Han Q; Cao YJ; Xu XS; Yang YP; Li J; Liu CF Mol Med Rep; 2011; 4(3):459-64. PubMed ID: 21468592 [TBL] [Abstract][Full Text] [Related]
20. Liquiritin attenuates advanced glycation end products-induced endothelial dysfunction via RAGE/NF-κB pathway in human umbilical vein endothelial cells. Zhang X; Song Y; Han X; Feng L; Wang R; Zhang M; Zhu M; Jia X; Hu S Mol Cell Biochem; 2013 Feb; 374(1-2):191-201. PubMed ID: 23229233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]